2020
DOI: 10.1016/j.ijbiomac.2020.03.140
|View full text |Cite
|
Sign up to set email alerts
|

Design and preparation of quaternized pectin-Montmorillonite hybrid film for sustained drug release

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(6 citation statements)
references
References 44 publications
0
5
0
1
Order By: Relevance
“…The 5-FU release rates were well fitted with the Elovich model compared to other models. The Ritger–Peppas model and the first-order model were applied to drug release to describe the drug release process in the alkaline region [ 51 ]. This resulted in multiple drug release mechanisms: (1) the membrane surface of 5-FU released in the simulated environment, (2) the membrane layer breaking of the PEM induced drug release in the 5-FU, (3) the high concentration of the 5-FU in the inner layer drove drug release, (4) the polymer–solvent interactions, as well as the polymer–solute interactions, meant that the pectin-Ca +2 -based films displayed a higher drug release rate, i.e., 63.89%, in simulated intestinal fluid [ 52 ].…”
Section: Resultsmentioning
confidence: 99%
“…The 5-FU release rates were well fitted with the Elovich model compared to other models. The Ritger–Peppas model and the first-order model were applied to drug release to describe the drug release process in the alkaline region [ 51 ]. This resulted in multiple drug release mechanisms: (1) the membrane surface of 5-FU released in the simulated environment, (2) the membrane layer breaking of the PEM induced drug release in the 5-FU, (3) the high concentration of the 5-FU in the inner layer drove drug release, (4) the polymer–solvent interactions, as well as the polymer–solute interactions, meant that the pectin-Ca +2 -based films displayed a higher drug release rate, i.e., 63.89%, in simulated intestinal fluid [ 52 ].…”
Section: Resultsmentioning
confidence: 99%
“…In principle, pectin consists of (1 → 4)-α-D-galacturonic acid (Gal A) residues with various neutral sugar branches. Pectin chains can be divided into “smooth regions,” which are linear anionic backbones without side chains, and “hairy regions,” which contain nonionic side chains (( Sriamornsak, 2003 , Meng et al, 2020 ). The structure of pectin is depicted in Fig.…”
Section: Pectin In Pharmaceutical Formulationsmentioning
confidence: 99%
“…The ability of pectin to form gels and interact with various substances is exploited in drug delivery systems, where it helps to control the release of medications over time. Furthermore, pectin has been used as a binder and disintegrant in pharmaceutical tablets to ensure proper drug absorption and effectiveness ( Meng et al, 2020 ).…”
Section: Pectin In Pharmaceutical Formulationsmentioning
confidence: 99%
“…The functional groups contained in pectin were modified according to the method of Yu-Jie Meng et al [7].…”
Section: Pectin Characterizationmentioning
confidence: 99%